ConductScience.org, home

Paper41269482

Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study.

Nouh I and 3 others. Int Urol Nephrol, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study. Papers, record 41269482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41269482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of daily silodosin 8 mg as a potential reversible male contraceptive: A prospective placebo controlled study.
PubMed
Journal
Int Urol Nephrol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IndolesMajor topic
Contraceptive Agents, MaleMajor topic
Humans
Male
Adult
Female
Prospective Studies
Pregnancy
Pregnancy Rate
Young Adult
Sperm Count
Double-Blind Method
Spermatozoa
Semen Analysis

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118379048Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay.Biol Pharm Bull2008https://conductscience.org/library/papers/18379048PubMed
224297884Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24297884PubMed
310224543Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth.Fam Plann Perspect1999https://conductscience.org/library/papers/10224543PubMed
429928620The future of male contraception: a fertile ground.Transl Androl Urol2018https://conductscience.org/library/papers/29928620PubMed
519536124Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration.Int J Impot Res2009https://conductscience.org/library/papers/19536124PubMed
631076850A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study.World J Urol2020https://conductscience.org/library/papers/31076850PubMed
723406327Which outcome expectancies are important in determining young adults' intentions to use condoms with casual sexual partners?: a cross-sectional study.BMC Public Health2013https://conductscience.org/library/papers/23406327PubMed
825951678World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.J Am Coll Dent2014https://conductscience.org/library/papers/25951678PubMed
932710833Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019.Lancet Glob Health2020https://conductscience.org/library/papers/32710833PubMed
101537032Chronic testicular pain following vasectomy.Br J Urol1992https://conductscience.org/library/papers/1537032PubMed
1136404279Abortion incidence and service availability in the United States, 2020.Perspect Sex Reprod Health2022https://conductscience.org/library/papers/36404279PubMed
126430643Phenoxybenzamine--an effective male contraceptive pill.Contraception1984https://conductscience.org/library/papers/6430643PubMed
1338101934Nonhormonal Male Contraceptive Development-Strategies for Progress.Pharmacol Rev2023https://conductscience.org/library/papers/38101934PubMed
1431692743Silodosin Has Nocebo Effect on Sexual Adverse Effects: A Randomized Controlled Trial.Eurasian J Med2019https://conductscience.org/library/papers/31692743PubMed
1535821454The P2X1 receptor as a therapeutic target.Purinergic Signal2022https://conductscience.org/library/papers/35821454PubMed
1626556545Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013.Natl Health Stat Report2015https://conductscience.org/library/papers/26556545PubMed
1721810189Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro.J Sex Med2012https://conductscience.org/library/papers/21810189PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42739649Alpha-Adrenoceptor Blockade as a Novel Pathway Toward Non-Hormonal Male Contraception: A Mechanistic and Clinical Evidence Review.J Clin Med2026https://conductscience.org/library/papers/42739649

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41269482

GET https://conductscience.org/api/papers/v1/41269482/authors